Targeting Survivin and molecular regulation of de-differentiated grade IV Astrocytoma (Glioblastoma)
Contribuinte(s) |
Kanwar (nee Kaur), Rupinder Kanwar Jagat Barrow, Colin |
---|---|
Data(s) |
01/09/2015
|
Resumo |
The study unprecendently provided evidence about the molecular understanding of a dedifferentiation phenotype of glioblastoma-a highly aggressive brain tumour with 12-15 months of patient survival after diagnosis. Further, the efficacies of survivin targeting molecules SurR9-C84A and a natural non-toxic protein bovine lactoferrin as a safe bio-drug to target glioblastoma were evaluated |
Identificador | |
Idioma(s) |
eng |
Publicador |
Deakin University, Faculty of Health, School of Medicine |
Relação |
http://dro.deakin.edu.au/eserv/DU:30085421/singh-agreement-2016.pdf http://dro.deakin.edu.au/eserv/DU:30085421/singh-targetingsurvivin-2016.pdf |
Direitos |
The author |
Palavras-Chave | #Chemotherapy #Radiotherapy #Cancer #Cell biology |
Tipo |
Thesis |